SAINT LAURENT, Quebec, April 08, 2024 IntelGenx Corp. today announced that Montelukast VersaFilm® has been administered to the first Parkinson’s Disease patients in the Phase 2 clinical.
IntelGenx Announces First Parkinson's Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ?MONTPARK' Clinical Trial lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
SAINT LAURENT, Quebec, April 05, 2024 IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response.
SAINT LAURENT, Quebec, March 11, 2024 IntelGenx Technologies Corp. announces that its wholly-owned subsidiary, IntelGenx Corp. , has entered into a third amended and restated loan agreement.
SAINT LAURENT, Quebec, Feb. 20, 2024 IntelGenx Corp. today announced the launch of a Regulation A offering of up to 2,000,000 shares of Series A Convertible Cumulative Preferred Stock , par.